LLC Sells 2700 Shares of AbbVie Inc. (ABBV)

Adjust Comment Print

About 204 shares traded.

Having a price of $73.37, AbbVie Inc (NYSE:ABBV) traded 1.95% higher on the day. It has underperformed by 6.07% the S&P500.

Orbis Investment Management decreased Carnival Corp (NYSE:CCL) stake by 18,891 shares to 61,760 valued at $3.22 million in 2016Q4.

The stock has Return on Assets (ROA) of 10 percent. Enstar Group Ltd now has $3.95B valuation. There were 2 death reports; 1 was a patient in the 15-mg dose group with cause of death unknown; the second was a patient in the 30-mg dose group who presented with fever and diarrhea, subsequent heart failure and presumed pulmonary embolism (PE) during hospitalization. About 14,580 shares traded. It is down 0.00% since September 12, 2016 and is. It has underperformed by 12.44% the S&P500. Its down 0.03, from 0.82 in 2016Q3. It improved, as 7 investors sold ESGR shares while 47 reduced holdings. 116 funds opened positions while 609 raised stakes. Shine Inv Advisory Ser holds 0.45% or 17,096 shares in its portfolio. Kistler accumulated 8,160 shares or 0.25% of the stock.

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company.

Multiple company employees have indulged in significant insider trading. Live Your Vision Ltd Llc owns 83 shares. The company has Beta Value of 1.47 and ATR value of 1.66. Brookmont Mngmt invested in 132,131 shares.

Are Antero Resources Corporation (NYSE:AR) Shares Headed For A Correction?
Morgan Stanley reaffirmed an "overweight" rating on shares of Antero Midstream GP in a research report on Tuesday, September 5th. Its up 0.25, from 0.77 in 2016Q3. 37,922 shares were sold by Schroepfer Michael Todd, worth $5.71 million on Tuesday, June 13.

In the phase 3 study, the safety profile of upadacitinib was consistent with previously reported phase 2 trials and the phase 3 SELECT-NEXT clinical trial reported in June. Bollard Group LLC now owns 3,764 shares of the company's stock worth $273,000 after purchasing an additional 19 shares during the last quarter.

Wharton Business Group Llc decreased Vanguard High Dividend (VYM) stake by 240,995 shares to 82,906 valued at $6.28M in 2016Q4. Qualcomm Inc (NASDAQ:QCOM) was reduced too.

ILLEGAL ACTIVITY WARNING: "AbbVie Inc". 16,000 shares were bought by Beattie William G, worth $448,800 on Monday, May 15. The company's shares were given away at $71.02 per share worth to an income of some $6,242,587 on account of Gonzalez Richard A. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2 average brokerage recommendation. Therefore 40% are positive. On average, equities analysts predict that AbbVie Inc. will post $5.48 EPS for the current year. Finally, Jefferies Group LLC reissued a "buy" rating on shares of AbbVie in a report on Friday, May 26th. JP Morgan maintained GlaxoSmithKline plc (ADR) (NYSE:GSK) on Wednesday, April 26 with "Neutral" rating. Citigroup Inc. reissued a "buy" rating on shares of AbbVie in a report on Tuesday, November 8th. CFRA downgraded the stock to "Hold" rating in Friday, July 21 report. The firm earned "Hold" rating on Friday, February 26 by Cantor Fitzgerald. The stock has "Sell" rating by Deutsche Bank on Monday, September 11. The firm has "Market Perform" rating by BMO Capital Markets given on Friday, June 10.

Since May 4, 2017, it had 0 insider buys, and 5 insider sales for $18.84 million activity. Suntrust Banks Inc. now owns 1,216,484 shares of the company's stock worth $79,265,000 after buying an additional 43,617 shares during the period. Therefore 75% are positive. Abbvie Inc had 48 analyst reports since July 21, 2015 according to SRatingsIntel. Schumacher Laura J also sold $5.59 million worth of AbbVie Inc (NYSE:ABBV) shares. $3.21 million worth of AbbVie Inc (NYSE:ABBV) was sold by ALBAN CARLOS. As per Friday, August 18, the company rating was maintained by Jefferies. The rating was maintained by Mizuho on Wednesday, August 9 with "Sell". The stock of Hudbay Minerals Inc (NYSE:HBM) earned "Underweight" rating by Barclays Capital on Thursday, January 14.

Investors sentiment increased to 0.93 in Q4 2016. Its up 0.01, from 0.99 in 2016Q3. It is positive, as 106 investors sold GILD shares while 656 reduced holdings. American National Bank raised its stake in shares of AbbVie by 13.8% in the first quarter. Vision Management stated it has 68,560 shares. Segall Bryant And Hamill Ltd Liability Company has 0.39% invested in AbbVie Inc (NYSE:ABBV). Delta Lloyd Nv has 153,609 shares for 0.3% of their portfolio. Liberty Incorporated holds 28,231 shares or 1.13% of its portfolio. Mirador Cap Prtnrs Lp has invested 0.61% of its portfolio in AbbVie Inc (NYSE:ABBV). Buckingham Asset Mgmt Lc reported 6,090 shares. 160,000 are held by Farallon Cap Management Ltd Liability. Moreover, Legacy Private Trust has 0.27% invested in AbbVie Inc (NYSE:ABBV). Gfs Limited Com stated it has 0.18% of its portfolio in AbbVie Inc (NYSE:ABBV). Cantab Capital Partners Llp bolstered its ownership by buying 7,295 shares an increase of 76.2% in the quarter. Oppenheimer, a New York-based fund reported 1,425 shares. Next Fincl Group Inc Inc holds 0% or 100 shares in its portfolio. Lba Wealth Mgmt accumulated 1,381 shares or 0.05% of the stock.

ABBV has been the topic of a number of research reports.